Shattuck Labs (STTK) Competitors $1.92 -0.06 (-3.03%) Closing price 04:00 PM EasternExtended Trading$1.86 -0.05 (-2.86%) As of 07:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock STTK vs. VYGR, CCCC, TNYA, TIL, MDWD, AARD, ENTA, TVGN, CGTX, and BIOAShould you be buying Shattuck Labs stock or one of its competitors? The main competitors of Shattuck Labs include Voyager Therapeutics (VYGR), C4 Therapeutics (CCCC), Tenaya Therapeutics (TNYA), Instil Bio (TIL), MediWound (MDWD), Aardvark Therapeutics (AARD), Enanta Pharmaceuticals (ENTA), Tevogen Bio (TVGN), Cognition Therapeutics (CGTX), and BioAge Labs (BIOA). These companies are all part of the "pharmaceutical products" industry. Shattuck Labs vs. Its Competitors Voyager Therapeutics C4 Therapeutics Tenaya Therapeutics Instil Bio MediWound Aardvark Therapeutics Enanta Pharmaceuticals Tevogen Bio Cognition Therapeutics BioAge Labs Shattuck Labs (NASDAQ:STTK) and Voyager Therapeutics (NASDAQ:VYGR) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, dividends, profitability, risk, analyst recommendations, valuation, earnings and institutional ownership. Is STTK or VYGR more profitable? Shattuck Labs has a net margin of 0.00% compared to Voyager Therapeutics' net margin of -253.49%. Voyager Therapeutics' return on equity of -37.65% beat Shattuck Labs' return on equity.Company Net Margins Return on Equity Return on Assets Shattuck LabsN/A -81.80% -71.46% Voyager Therapeutics -253.49%-37.65%-28.89% Do insiders & institutionals hold more shares of STTK or VYGR? 58.7% of Shattuck Labs shares are held by institutional investors. Comparatively, 48.0% of Voyager Therapeutics shares are held by institutional investors. 12.0% of Shattuck Labs shares are held by company insiders. Comparatively, 6.4% of Voyager Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has more volatility and risk, STTK or VYGR? Shattuck Labs has a beta of 1.64, suggesting that its share price is 64% more volatile than the S&P 500. Comparatively, Voyager Therapeutics has a beta of 0.9, suggesting that its share price is 10% less volatile than the S&P 500. Which has better earnings and valuation, STTK or VYGR? Voyager Therapeutics has higher revenue and earnings than Shattuck Labs. Voyager Therapeutics is trading at a lower price-to-earnings ratio than Shattuck Labs, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioShattuck Labs$5.72M16.08-$75.41M-$1.21-1.59Voyager Therapeutics$80M2.90-$65M-$1.85-2.26 Does the media favor STTK or VYGR? In the previous week, Shattuck Labs had 21 more articles in the media than Voyager Therapeutics. MarketBeat recorded 23 mentions for Shattuck Labs and 2 mentions for Voyager Therapeutics. Voyager Therapeutics' average media sentiment score of 1.81 beat Shattuck Labs' score of 1.00 indicating that Voyager Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Shattuck Labs 2 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Voyager Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do analysts prefer STTK or VYGR? Shattuck Labs currently has a consensus target price of $4.00, suggesting a potential upside of 108.33%. Voyager Therapeutics has a consensus target price of $13.25, suggesting a potential upside of 216.92%. Given Voyager Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Voyager Therapeutics is more favorable than Shattuck Labs.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Shattuck Labs 0 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 2.86Voyager Therapeutics 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.13 SummaryShattuck Labs beats Voyager Therapeutics on 9 of the 17 factors compared between the two stocks. Get Shattuck Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for STTK and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding STTK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart STTK vs. The Competition Export to ExcelMetricShattuck LabsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$91.97M$3.12B$5.78B$10.15BDividend YieldN/A2.32%5.69%4.61%P/E Ratio-1.5921.3074.5925.92Price / Sales16.08258.41453.9085.92Price / CashN/A45.3337.0859.91Price / Book1.159.6112.156.29Net Income-$75.41M-$53.29M$3.28B$270.85M7 Day Performance23.87%0.29%0.98%3.36%1 Month Performance151.80%8.91%7.20%6.41%1 Year Performance-47.97%13.14%63.06%28.26% Shattuck Labs Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)STTKShattuck Labs3.9248 of 5 stars$1.92-3.0%$4.00+108.3%-46.9%$91.97M$5.72M-1.59100Positive NewsShort Interest ↓Analyst RevisionVYGRVoyager Therapeutics3.9507 of 5 stars$3.36-1.2%$13.25+294.3%-30.3%$186.38M$80M-1.82100Positive NewsCCCCC4 Therapeutics2.9877 of 5 stars$2.60+2.0%$8.00+207.7%-54.5%$185.04M$35.58M-1.65150TNYATenaya Therapeutics3.3092 of 5 stars$1.13flat$6.25+453.1%-41.8%$184.16MN/A-1.18110Gap UpTILInstil Bio2.8817 of 5 stars$27.00-2.3%$119.00+340.7%-19.7%$182.27MN/A-2.09410Analyst ForecastInsider TradeMDWDMediWound1.6388 of 5 stars$16.70-0.7%$32.25+93.1%+11.4%$180.49M$20.22M-6.3380Gap UpAARDAardvark Therapeutics3.6915 of 5 stars$8.30-2.2%$32.60+292.8%N/A$180.08MN/A0.0018News CoverageENTAEnanta Pharmaceuticals4.1772 of 5 stars$8.40-3.3%$21.67+157.9%-28.1%$179.57M$67.64M-1.94160TVGNTevogen Bio3.9082 of 5 stars$0.91+0.8%$10.00+998.9%+101.3%$179MN/A0.003CGTXCognition Therapeutics2.8224 of 5 stars$2.43-2.0%$2.83+16.6%+288.3%$178.66MN/A-3.6320Short Interest ↑BIOABioAge Labs0.1992 of 5 stars$4.93+2.7%N/AN/A$176.74MN/A0.00N/APositive News Related Companies and Tools Related Companies Voyager Therapeutics Competitors C4 Therapeutics Competitors Tenaya Therapeutics Competitors Instil Bio Competitors MediWound Competitors Aardvark Therapeutics Competitors Enanta Pharmaceuticals Competitors Tevogen Bio Competitors Cognition Therapeutics Competitors BioAge Labs Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:STTK) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredWall Street laughed at Trump’s “Smart Dollar.” Now they’re all in."THIS is the Biggest Economic Story of 2025" While most Americans are focused on tariffs and inflation, the...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shattuck Labs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Shattuck Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free STTK Stock Alerts